BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22002196)

  • 1. Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii.
    Caetano BC; Biswas A; Lima DS; Benevides L; Mineo TW; Horta CV; Lee KH; Silva JS; Gazzinelli RT; Zamboni DS; Kobayashi KS
    Eur J Immunol; 2011 Dec; 41(12):3627-31. PubMed ID: 22002196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.
    Shaw MH; Reimer T; Sánchez-Valdepeñas C; Warner N; Kim YG; Fresno M; Nuñez G
    Nat Immunol; 2009 Dec; 10(12):1267-74. PubMed ID: 19881508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.
    Collazo CM; Miller C; Yap G; Hieny S; Caspar P; Schwartz RH; Sher A
    Infect Immun; 2000 May; 68(5):2713-9. PubMed ID: 10768964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infection.
    Lupfer C; Thomas PG; Kanneganti TD
    J Virol; 2014 Aug; 88(16):8946-55. PubMed ID: 24872587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
    Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
    J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.
    Johnson LL; Sayles PC
    Infect Immun; 2002 Jan; 70(1):185-91. PubMed ID: 11748181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis.
    Heimesaat MM; Dunay IR; Alutis M; Fischer A; Möhle L; Göbel UB; Kühl AA; Bereswill S
    PLoS One; 2014; 9(8):e105120. PubMed ID: 25141224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3-dependent CD4⁺ T cells are required to activate inflammatory monocytes for defense against intestinal infection.
    Cohen SB; Maurer KJ; Egan CE; Oghumu S; Satoskar AR; Denkers EY
    PLoS Pathog; 2013; 9(10):e1003706. PubMed ID: 24130498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
    Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
    Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
    Gigley JP; Fox BA; Bzik DJ
    J Immunol; 2009 Jan; 182(2):1069-78. PubMed ID: 19124750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses.
    Wilson EH; Zaph C; Mohrs M; Welcher A; Siu J; Artis D; Hunter CA
    J Immunol; 2006 Aug; 177(4):2365-72. PubMed ID: 16887998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.
    Lieberman LA; Villegas EN; Hunter CA
    Infect Immun; 2004 Nov; 72(11):6729-32. PubMed ID: 15501812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.
    Combe CL; Curiel TJ; Moretto MM; Khan IA
    Infect Immun; 2005 Aug; 73(8):4913-21. PubMed ID: 16041005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation.
    Yang Z; Gu P; Shao X; Li Z; Zhou Y; Lu L; Chou KY
    J Biol Chem; 2012 Mar; 287(13):9972-9981. PubMed ID: 22294690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.
    Divangahi M; Mostowy S; Coulombe F; Kozak R; Guillot L; Veyrier F; Kobayashi KS; Flavell RA; Gros P; Behr MA
    J Immunol; 2008 Nov; 181(10):7157-65. PubMed ID: 18981137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii infection inhibits Th17-mediated spontaneous development of arthritis in interleukin-1 receptor antagonist-deficient mice.
    Washino T; Moroda M; Iwakura Y; Aosai F
    Infect Immun; 2012 Apr; 80(4):1437-44. PubMed ID: 22290145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
    Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
    Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.
    Mahamed DA; Toussaint LE; Bynoe MS
    Infect Immun; 2015 Feb; 83(2):721-9. PubMed ID: 25452548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells.
    Casciotti L; Ely KH; Williams ME; Khan IA
    Infect Immun; 2002 Feb; 70(2):434-43. PubMed ID: 11796568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.